Abstract Intra-lesional venous lumen shrinking detectable by MRI was suggested as an in vivo marker of inflammation in multiple sclerosis (MS). In our study mean diameters of pre-, post-and intra-lesional venous sections were determined in 49 patients with MS or clinically isolated syndrome (CIS) using a pixel-wise analysis on susceptibility-weighted fluid-attenuated inversion recovery (sFLAIR) images and T2*-weighted (T2*w) imaging at 7 Tesla (T). We observed post-tointra-lesional venous lumen shrinking on T2*w images (p = 0.036) in an analysis of 338 venous sections. Pre-tointra-lesional venous lumen reduction was only detectable in less than 50 % of lesions and failed statistical significance when analysing T2*w (p = 0.325) and sFLAIR images (p = 0.258). In conclusion, thinning of intra-lesional veins in MS is-if detectable at all-probably less severe than previously reported, and affects only a minority of MS lesions.
Introduction
Perivascular inflammation plays a key role in multiple sclerosis (MS) typically causing cockscomb-like lesions visualized by MRI [1, 2] . Since immune cell invasion into the MS brain parenchyma requires extravasation through the vessel wall into the perivascular space [3] , alterations of the vessel wall, endothelial tight junctions and basal lamina alterations, perivascular cuffing, as well as thickened vein walls containing fibrinoid have been reported in MS [4] [5] [6] . It was suggested that an obstruction and consequently reduced blood flow in intra-lesional MS veins lead to macroscopically visible changes detectable by MRI at 3 Tesla (T) [7] . Yet, the possibility to analyse these changes may have been limited by partial volume effects, spatial resolution constraints and limited lesion-to-vein contrast when using conventional T2*-weighted (T2*w) imaging [7] .
Combining fluid-attenuated inversion recovery (FLAIR) and susceptibility-weighted imaging (SWI) at 7-T enables the detection of both, lesions and small veins, due to improved signal-to-noise ratio, lesion-to-tissue contrast and increased susceptibility effects. Here, we compare diameters of venous sections in relation to MS lesions by susceptibility-weighted FLAIR (sFLAIR) and T2*w imaging using a pixel-wise quantification algorithm.
Methods

Study participants
We enrolled 49 patients with MS (relapsing remitting MS n = 35, primary progressive MS n = 9) or clinically isolated syndrome (CIS, n = 5, Table 1 ). The study was approved by the local ethics committee (EA 1/054/09) and all participants gave informed written consent prior to the study.
MRI data acquisition
MRI was performed on a 7-T whole body system (Magnetom; Siemens, Erlangen, Germany) equipped with a 24-channel receive head coil (Nova Medical, Wilmington, MA, USA). The imaging protocol included two-dimensional axial T2*w fast low-angle shot (FLASH, TE = 25 ms, TR = 1,820 ms, in plane spatial resolution = (0.5 9 0.5) mm 2 , slice thickness = 2 mm), FLAIR (TE = 90 ms, TR = 16,000 ms, TI = 2,925.5 ms, in plane spatial resolution = (1.0 9 1.0) mm 2 , slice thickness = 3 mm, n = 43), and SWI (TE = 14 ms, TR = 25 ms, in plane spatial resolution = (0.5 9 0.5) mm 2 , slice thickness = 1 mm, n = 31) sequences.
MRI post processing
By fusion of FLAIR and SWI images, partial volume effects caused by surrounding edema were reduced if not eliminated which affords an improved reliability of the analysis of venous diameter. Following a previous report on T2*w fluid-attenuated inversion recovery (FLAIR*) [8] , the MIPAV software package (version 7.0.1, Bethesda, Maryland, USA) was used to calculate sFLAIR as the sum Gender (female) 20
Age, mean ± SD, range (years) 38 ± 9, 19-55 of the co-registered, homogenized FLAIR and the unmodified SWI.
Image analysis MRI data were analysed by a blinded investigator and subsequently confirmed by a 7-T MRI experienced neuroradiologist using OsiriX (version 5.7 32 bit; OsiriX Foundation, Geneva, Switzerland). T2 lesion count was determined on T2*w images, with a lesion being defined by at least three voxels showing enhanced contrast versus surrounding brain tissue. FLAIR images were used to confirm lesion presence.
Measurement of venous diameter
We quantified the mean venous diameter of the pre-, post-, and intra-lesional section of a given vein of interest. The intra-lesional section of the vein was defined as the central third of the venous length with a third of its length as a spacer to each of the edges of the lesion. Thus, only lesions with a detectable length of 4 mm or more were analysed to ensure a minimum of two voxels covering the intra-lesional vein section. The post-and pre-lesional section was determined by taking the length of the intra-lesional vein as a reference (Fig. 1a) . Next, venous diameter was analysed on T2*w FLASH images and minimal intensity projection maps of two sFLAIR images (Fig. 1a) : each venous voxel of the given venous section of interest was subsequently marked as described previously [9] to calculate mean venous diameter by the use of Pythagoras' theorem: mean venous diameter (mm) = [H (number of horizontal voxel 2 ? number of vertical voxel 2 )/total number of voxel] 9 spatial resolution (mm).
Statistical analysis
To analyse differences in venous diameter between intralesional and corresponding pre-or post-lesional venous sections, non-parametric Wilcoxon signed-rank test for paired samples was calculated using IBM SPSS Statistics (version 20, IBM, Somers, NY, USA); p values\0.05 were considered significant.
Results
Intra-lesional venous diameter on T2*w images
In total, we detected 1,857 MS lesions, and we could analyse 193 venous sections (pre-lesional venous sections Mean diameter of extra-and intra-lesional venous sections of one continuously displayed vein (red line) was assessed by marking venous voxel (blue area) showing a 10 % lower signal intensity than the reference region of interest (red circle) to calculate mean venous diameter. b T2*w imaging visualizes intra-lesional venous lumen shrinking that is not detectable on corresponding sFLAIR image n = 71, post-lesional venous sections n = 29, intra-lesional venous sections n = 93) of 93 continuously displayed veins in 31 of 49 patients on T2*w images. The mean diameter of each analysed intra-lesional venous section was compared to the mean diameter of its accompanying pre-and post-lesional section. Intra-lesional venous sections were partially thinner than post-lesional (p = 0.036) sections. However, differences in venous diameter between intra-lesional and pre-lesional (p = 0.325) venous sections were not significant.
In detail, a smaller intra-lesional venous diameter was only detectable in 32 of 71 veins (45 %) when comparing pre-and intra-lesional venous sections. Those 32 shrinked intra-lesional venous sections showed a mean decrease in venous diameter of 20 % [standard deviation (SD) 12 %, range 4-50 %]. When comparing post-and intra-lesional venous sections, an intra-lesional lumen shrinking of venous diameter was observed in 19 of 29 veins (66 %) showing a mean decrease of 18 % (SD 12 %, range 3-47 %).
Intra-lesional venous diameter in sFLAIR images
Analysis of 69 continuously displayed veins within 18 of 49 patients using sFLAIR images in 145 venous sections (pre-lesional venous sections n = 47, post-lesional venous sections n = 29, intra-lesional venous sections n = 69) revealed that intra-lesional venous lumen shrinking-if depicted at all-was visually less severe than displayed on T2*w images (Fig. 1b) . Statistical analyses revealed no differences between intra-lesional and pre-or post-lesional venous diameters (Table 1) .
Discussion
This work adds to the literature by comparing intra-lesional venous diameters to adjacent pre-and post-lesional sections of the same vein. In line with a recent 3-T work using contrast-enhanced T2*w imaging [7] , intra-lesional venous sections were in part visually smaller compared to pre-or post-lesional venous areas on T2*w. Given the physiological reduction of venous diameter from distal to proximal a comparison between pre-and intra-lesional venous diameter is needed when analysing intra-lesional venous lumen shrinking of the same vein. Our study failed to provide strong evidence of pre-to-intra-lesional venous lumen shrinking since the latter was only detectable in less than 50 % of veins.
To overcome the limitations of T2*w imaging such as partial volume effects of the surrounding edema [7] , we fused FLAIR and SWI that is highly sensitive in depicting venous structures. Although we observed marginal, but significant post-to-intra-lesional venous lumen shrinking when analysing T2*w images, sFLAIR revealed intra-lesional venous diameter being visually and statistically not smaller compared to adjacent pre-or post-lesional venous sections. We relate these differences to less partial volume effects in sFLAIR caused by surrounding edema. However, we cannot exclude the possibility that ''blooming'' effects caused by deoxyhemoglobin-related susceptibility effects and limitations resulting from the spatial resolution of only 0.5 9 0.5 mm 2 -which causes a low number of analysable venous voxels in some lesions-may have led to an underestimation of venous lumen shrinking. We used a shorter TE in sFLAIR compared to T2*w imaging to reduce those ''blooming'' effects. Hence, measures of venous diameters on sFLAIR images were generally smaller than measures of venous diameters on T2*w images.
According to pathology studies damaged and fibrinogen-thickened MS vein walls [4] [5] [6] may cause venous narrowing or obstruction visible on susceptibility-weighted images. Hence, one could assume that the extent of inflammation is associated with the degree of venous lumen shrinking. The present dataset, however, was too small to allow a correlation between venous diameter and clinical parameters such as relapse rates or EDSS.
In conclusion, intra-lesional venous lumen shrinking in MS is-if detectable at all-probably less severe than suggested and affects only a minority of MS lesions. Future combined post mortem and 7-T sFLAIR MRI studies with enhanced spatial resolution will show whether this subgroup of MS lesions is characterized by a higher degree of perivascular inflammation.
